Lv1
90 积分 2023-09-19 加入
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
2小时前
待确认
First-Line Zongertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
3小时前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
10小时前
已完结
祝朝富从“补托法”论治肠癌化疗相关性腹泻经验
4个月前
已关闭
Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial
4个月前
已完结
皖公网安备34019202002308
